Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pralle

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Blood|July 1, 1991
Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemiaP von Wussow, H Pralle, H K Hochkeppel, et al.
Leukemia & Lymphoma|January 1, 1993
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1R Hehlmann, H Heimpel, H J Kolb, et al.
British Journal of Haematology|December 31, 1997
Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantroneR F Schlenk, H Döhner, M Pförsich, et al.
British Journal of Haematology|April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study GroupR Hehlmann, H Ansari, J Hasford, et al.
Leukemia|April 15, 2005
Gender aspects in chronic myeloid leukemia: long-term results from randomized studiesU Berger, O Maywald, M Pfirrmann, et al.
Leukemia|April 1, 1997
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study GroupR Hehlmann, A Willer, H Heimpel, et al.
The New England Journal of Medicine|August 16, 1979
Heterogeneity of diffuse "histiocytic" lymphoma according to the Kiel classificationP Meusers, H Bartels, G Brittinger, et al.
Leukemia|September 13, 2003
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alphaU Berger, G Engelich, O Maywald, et al.
Leukemia Research|January 1, 1982
Multicentre study on intensified remission induction therapy for acute myeloid leukemiaT Büchner, D Urbanitz, B Emmerich, et al.
Leukemia|July 30, 2003
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trialR F Schlenk, A Benner, F Hartmann, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Blood|July 1, 1991
Effective natural interferon-alpha therapy in recombinant interferon-alpha-resistant patients with hairy cell leukemiaP von Wussow, H Pralle, H K Hochkeppel, et al.
Leukemia & Lymphoma|January 1, 1993
The German CML study, comparison of busulfan vs. hydroxyurea vs. interferon alpha and establishment of prognostic score 1R Hehlmann, H Heimpel, H J Kolb, et al.
British Journal of Haematology|December 31, 1997
Successful collection of peripheral blood progenitor cells in patients with acute myeloid leukaemia following early consolidation therapy with granulocyte colony-stimulating factor-supported high-dose cytarabine and mitoxantroneR F Schlenk, H Döhner, M Pförsich, et al.
British Journal of Haematology|April 1, 1997
Comparative analysis of the impact of risk profile and of drug therapy on survival in CML using Sokal's index and a new score. German chronic myeloid leukaemia (CML)-Study GroupR Hehlmann, H Ansari, J Hasford, et al.
Leukemia|April 15, 2005
Gender aspects in chronic myeloid leukemia: long-term results from randomized studiesU Berger, O Maywald, M Pfirrmann, et al.
Leukemia|April 1, 1997
Randomized studies with interferon in chronic myelogenous leukemia (CML) and comparative molecular aspects. German CML Study GroupR Hehlmann, A Willer, H Heimpel, et al.
The New England Journal of Medicine|August 16, 1979
Heterogeneity of diffuse "histiocytic" lymphoma according to the Kiel classificationP Meusers, H Bartels, G Brittinger, et al.
Leukemia|September 13, 2003
Chronic myeloid leukemia in the elderly: long-term results from randomized trials with interferon alphaU Berger, G Engelich, O Maywald, et al.
Leukemia Research|January 1, 1982
Multicentre study on intensified remission induction therapy for acute myeloid leukemiaT Büchner, D Urbanitz, B Emmerich, et al.
Leukemia|July 30, 2003
Risk-adapted postremission therapy in acute myeloid leukemia: results of the German multicenter AML HD93 treatment trialR F Schlenk, A Benner, F Hartmann, et al.
Pageof 11